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Probiotic modulation of the 
microbiota-gut-brain axis and 
behaviour in zebrafish
Luca Borrelli1,*, Serena Aceto2,*, Claudio Agnisola2, Sofia De Paolo2, Ludovico Dipineto1, 
Roman M. Stilling3, Timothy G. Dinan3,4, John F. Cryan3,5, Lucia F. Menna1 & 
Alessandro Fioretti1
The gut microbiota plays a crucial role in the bi-directional gut–brain axis, a communication that 
integrates the gut and central nervous system (CNS) activities. Animal studies reveal that gut bacteria 
influence behaviour, Brain-Derived Neurotrophic Factor (BDNF) levels and serotonin metabolism. In 
the present study, we report for the first time an analysis of the microbiota–gut–brain axis in zebrafish 
(Danio rerio). After 28 days of dietary administration with the probiotic Lactobacillus rhamnosus IMC 
501, we found differences in shoaling behaviour, brain expression levels of bdnf and of genes involved 
in serotonin signalling/metabolism between control and treated zebrafish group. In addition, in 
microbiota we found a significant increase of Firmicutes and a trending reduction of Proteobacteria. 
This study demonstrates that selected microbes can be used to modulate endogenous neuroactive 
molecules in zebrafish.
There is an emerging understanding of the bi-directional crosstalk governing gut-to-brain communication in 
health and disease of both organs. Accordingly, not only the brain can affect gut functions, but the gut can also 
induce changes in the central nervous system (CNS) and there is now compelling evidence for various links 
between the enteric microbiota and brain function1–3. This connection is becoming increasingly relevant in 
novel therapeutic strategies to target psychiatric disorders such as depression and anxiety disorders. As such, 
it has been shown that absence or modification of the enteric microbiota affects stress-associated anxiety-like 
and depressive-like behaviours4,5. This has lead to the postulation of psychobiotics, i.e. live microorganisms that 
have beneficial psychotropic effects on the host6. To date, multiple probiotic bacteria with psychotropic potential 
have been identified, including strains of the genera Bifidiobacterium7–10, Lactobacillus9–12 and Enterococcus13. 
A very promising potential psychobiotic with demonstrated effectivity in mice and humans is Lactobacillus 
rhamnosus11,12.
Importantly, the microbiota has been implicated in altering neurotrophic factors7,8,14–17, a class of proteins 
playing roles in controlling neuronal function and maintaining cellular integrity, survival, differentiation, and 
synaptic plasticity18–20. Among all neurotrophins, Brain Derived Neurotrophic Factor (BDNF) is the most well 
conserved throughout vertebrate evolution1,21,22. As such, the primary amino acid sequences of zebrafish (Danio 
rerio) and human BDNF are 91% identical22–24. While the distribution pattern of bdnf mRNA and protein has 
been described in the CNS of rat25, mouse26, human27 and zebrafish28, BDNF has also been observed in other 
organs and tissues of adult and developing zebrafish29. Changes in BDNF signalling is relevant to a range of 
human neuronal and psychiatric disorders30, as well as to biological systems involved in the stress response31.
Using rodents as model organisms, multiple studies have also implicated the microbiota in regulation of 
serotonin signalling and metabolism16,32,33. The monoamine serotonin, or 5-hydroxytryptamine (5-HT), is one 
of the primary neurotransmitters modulating physiological and behavioural processes in the CNS34–36 and the 
serotonergic system is highly conserved in vertebrate species. Also zebrafish Danio rerio possesses a complex 
serotonergic system featuring all major genes for 5-HT synthesis, metabolism and signalling37, similar to those 
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observed in humans and rodents38. As such, zebrafish possess three copies of the tph gene (tph1a, tph1b and tph2) 
encoding tryptophan hydroxylase, the rate-limiting enzyme in serotonin synthesis, two genes encoding serotonin 
transporters homologous to those of vertebrates, slc6a4a and slc6a4b (previously serta and sertb)34, and multiple 
receptors homologs, e.g. htr1aa, homologue of the mammalian serotonin receptor 1A, and htr1ab, specific of 
fishes. Zebrafish also have one functional monoamine oxidase gene (mao) exhibiting a strong affinity profile for 
serotonin37,39. Zebrafish is a well-known model organism, increasingly used in translational neuroscience and 
behavioural research40. Interestingly, it is a highly social species and shoaling is a typical group forming behaviour 
often seen in cyprinids (Cyprinidae). Shoaling behaviour has been observed both in nature41 and in the labora-
tory42,43 as one of the most robust and consistent behavioural features of this species40.
To explore probiotics as potential therapeutic psychotropic agents in psychiatric diseases and to further high-
light the use of the zebrafish model to describe the impact of psychobiotics on brain function and behaviour, 
we here assessed the effects of the probiotic strain Lactobacillus rhamnosus IMC 501 on shoaling behaviour in 
healthy, wild-type zebrafish. This strain was already used in zebrafish, where it generates beneficial effects such as 
reduction of hepatic cholesterol level, improved adsorption of nutrients and increased production of short-chain 
fatty acids44. Moreover, we investigate central and peripheral expression levels of the bdnf gene and of the sero-
tonergic genes tph1a, tph1b, tph2, htr1aa, slc6a4a and mao, in brain and gut of zebrafish. We also evaluated the 
microbiota profile by using 16S rRNA sequencing after probiotic administration.
Results
L. rhamnosus administration changes shoaling behaviour. Zebrafish shoaling behaviour was ana-
lysed for Average Distance (AD), Distance Variance (DV), Nearest Distance (ND), Occupied Area (OA), Column 
Preference (CP) and Shuttling Frequency (SF) at day 0 and after 4 weeks in both control (CTRL) and probiotic 
treated (PROBIO) groups. Control group (CTRL) displayed behavioural adaptation to the tank during the 4 
weeks of treatment (Fig. 1). In particular, AD and DV significantly increased, while CP significantly decreased. 
As shoal size area (OA) did not change, these data indicate that after adaptation animals were less uniformly 
distributed in the shoal, and tended to spend most of their time in the upper part of the tank. Shoal cohesion 
of zebrafish fed with probiotics (PROBIO) was significantly different from controls (CTRL) (Fig. 1). Although 
AD was not significantly different between the two groups for treatment, DV (Finteraction = 17.79, p < 0.0001) and 
ND (Ftreatment = 7.948, p = 0.0059) showed significant dependence on treatment and time (Table S1). OA, was 
also significantly increased in the PROBIO group (Finteraction = 4.423, p = 0.0483). The two groups showed com-
pletely different preferences for location in the water column (CP) (Finteraction = 377.8, p < 0.0001) (Table S1). More 
importantly, SF (Finteraction = 7.862, p = 0.0127) was strongly increased in the PROBIO group. Together, these data 
suggest that feeding of the probiotic L. rhamnosus IMC 501 significantly alters social and explorative behaviour 
in zebrafish (Video S1).
Probiotic administration modulates the gut microbial communities. The α -diversity indices 
Chao1 (138.02 ± 40.36 CTRL, 133.25 ± 30.00 PROBIO) and Shannon (4.12 ± 0.59 CTRL, 3.92 ± 0.97 PROBIO) 
of the gut microbiota in CTRL and PROBIO zebrafish were not significantly different, indicating that the die-
tary administration of L. rhamnosus does not affect overall richness of the zebrafish gut bacterial community. 
Similarly, weighted two-dimensional Principal Coordinates Analysis showed that PROBIO samples largely clus-
tered with CTRL samples, demonstrating overall similarity of the gut bacterial communities between the two 
groups (Fig. 2A). However, we noticed differences at the phylum and class levels (Fig. 2B,C). Fusobacteria domi-
nated both groups, accounting for 75.83% (CTRL) and 61.18% (PROBIO) of the OTUs retrieved. Proteobacteria 
(17.24% CTRL, 9.01% PROBIO), Firmicutes (4.10% CTRL, 28.75% PROBIO), and Cyanobacteria (0.97% CTRL, 
0.19% PROBIO) were also present in both groups, yet at different abundances. Actinobacteria were present only 
in the CTRL (1,86%) and Bacteroidetes (0.78%) only in the PROBIO samples. The abundance of Lactobacillus 
(8,3%) in the PROBIO group is likely representative of the dietary administration of L. rhamnosus (Phylum: 
Firmicutes, Class: Bacilli), suggesting that the fed probiotic bacteria colonised the gut, in agreement with previ-
ous studies45–47. In addition, in the PROBIO group there is a significant increase of the Streptococcus genus (t-test 
p value 0.025, Table S2; Fig. 2D). The abundance of both Lactobacillus and Streptococcus might be related to the 
symbiotic relationship between L. rhamnosus and Streptococcus thermophilus described in zebrafish after probi-
otic administration44,46,47. On average, Proteobacteria, that include potentially pathogenic genera (e.g. Vibrio and 
Plesiomonas, Fig. 2D), were less represented in the PROBIO group (9.01%) than in the CTRL (17.84%), although 
this difference was not statistically significant.
Probiotic feeding induces changes in neuronal gene expression in brain and gut. Previous 
studies on the gut-brain axis in rodent models have repeatedly shown altered expression of bdnf in certain 
brain regions under various conditions7,8,14,15,17. In addition, BDNF signalling is known to be involved in social 
behaviour48,49. As such, the expression of bdnf in the brains of rodent models is very plastic and regulated in a 
dynamic way. A very well-studied molecular pathway resulting in elevated levels of bdnf mRNA is the CREB 
(cAMP response element binding protein) signalling pathway that gets activated upon neuronal excitation. Many 
behavioural paradigms have been shown to induce bdnf expression in various brain regions including novelty 
exposure (e.g. social novelty, novel environment, environmental enrichment) and learning tasks. On the other 
hand, a reduction in bdnf levels is often a signature of reduced cognitive abilities. Importantly, reduced levels of 
bdnf have been associated with depression and it has been suggested that conventional antidepressants and keta-
mine mediate their antidepressant-like effects by increasing bdnf in particular in the hippocampus, making it an 
essential determinant of antidepressant efficacy50. We therefore determined if the expression of bdnf was altered 
after probiotic administration in zebrafish. In the brain, the PROBIO group showed a significant (near two-fold) 
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increase of bdnf expression compared to the CTRL group (t-test p value 0.001) (Fig. 3A). In contrast, we did not 
detect any significant difference between the PROBIO and CTRL groups in the gut, although there was a trend 
towards decreased expression.
Furthermore, socio-emotional behaviour in vertebrates is heavily dependent on the serotonergic system51,52. 
Moreover, microbial influence on the serotonergic system has been proposed as a key mediator of gut-brain 
signalling16,33. Therefore, we next investigated potential changes in expression of selected genes involved in ser-
otonin signalling and metabolism (tph1a, tph1b, tph2, htr1aa, slc6a4a and mao), both in the gut and in the brain 
of zebrafish fed with L. rhamnosus IMC 501 (Fig. 3B). In the brain, five genes showed a statistically significant 
increase of the relative expression levels in the PROBIO group (t-test p values: tph1a 0.03, tph2 0.01, htr1aa 0.01, 
slc6a4a 0.004 and mao 0.0003), indicating that the probiotic administration changes the expression levels of 
genes involved in the serotonergic system. In contrast, in the gut, we detected a reduction of the expression levels 
for the genes tph1a (t-test p value 0.001), tph1b (p = 0.001) and htr1aa (p = 0.03), while the other genes did not 
show significant differences between the PROBIO and CTRL groups. Together, these data suggest tissue-specific 
modulation of the serotonergic system.
Figure 1. Probiotic treatment alters zebrafish shoaling behaviour. Average Distance (AD), Distance Variance 
(DV), Nearest Distance (ND), Occupied Area (OA), Column Preference (CP) and Shuttling Frequency (SF) 
measurements (Supplementary Figure 1) at the beginning (T0) and end of 4 weeks (T4) of probiotic treatment, 
are shown from both control (CTRL) and treated (PROBIO) animals. Bars represent SEM. #indicates significant 
difference from T0 (Two-way ANOVA with Sidak’s post-hoc test, p < 0.05); asterisks indicate statistical 
significant difference between the CTRL and PROBIO groups (Two-way ANOVA with Sidak’s post-hoc test:  
* * * p < 0.001, **p < 0.01, * p < 0.05). DV Finteraction = 17.79, p < 0.0001; ND Ftreatment = 7.948, p = 0.0059;  
OA Finteraction = 4.423, p = 0.0483; CP Finteraction = 377.8, p < 0.0001; SF Finteraction = 7.862, p = 0.0127.
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Figure 2. Whole intestine bacterial community analysis of adult zebrafish after probiotic treatment.  
(A) Principal coordinates analysis (PCoA) plots using weighted UnicFrac distances. Stacked bar chart 
representing the relative abundance of bacterial phylum (B) and classes (C). (D) Fold change of the genus 
Lactobacillus, Streptococcus, Plesiomonas and Vibrio in the PROBIO relative to the CTRL group.
Figure 3. Probiotic feeding induces changes in neuronal gene expression in brain and gut. Relative 
expression of the D. rerio bdnf (A) and tph1a, tph1b, tph2, htr1aa, slc6a4a, mao (B) genes in brain and gut of 
zebrafish treated with L. rhamnosus (PROBIO) and controls (CTRL). The mean relative expression levels of the 
PROBIO group are normalized to the mean relative expression of the CTRL group. AU, arbitrary units. Bars 
represent SEM. Asterisks indicate statistical significant difference between the CTRL and PROBIO groups: 
**t-test p < 0.01, * t-test p < 0.05.
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Discussion
Zebrafish is an increasingly important model organism in neuroscientific basic and translational research53. 
Zebrafish digestive tract is similar to that of mammals in its development, organisation and function and zebrafish 
are well suited for studying host-microbe interactions as they have innate and adaptive immune systems similar 
to higher vertebrates54. Surprisingly, to our knowledge, there have been no studies yet investigating the influence 
of beneficial or commensal gut microbes on the gut-brain axis in this model organism. Yet, host-microbe inter-
actions in the gut are now widely accepted to affect brain function and behaviour and considered as a potential 
target in psychiatric diseases55. We have therefore decided to explore the effects of feeding healthy, wild-type 
zebrafish with the probiotic strain L. rhamnosus IMC 501 on shoaling behaviour, a measure of basal exploratory 
and social behaviour.
In our study the shoaling pattern of zebrafish differed significantly from controls after 4 weeks of probiotic 
treatment. In particular, the probiotic treated group was more uniform and showed more homogeneity within 
the shoal as evidenced by a decreased average distance variance (DV). In addition, the nearest distance (ND) and 
occupied shoal area (OA) were significantly increased after treatment. Concerning the water column preference 
(CP), the PROBIO group showed a completely different behavioural pattern. While the control group changed 
significantly to prefer the upper parts of the water tank at the end of the 4 weeks of observation, which is likely 
due to habituation to the aquarium, the probiotic treated group continued to prefer the medium/deeper part 
of the tank. Furthermore, a significant increase in shuttling frequency (SF) indicates a strong increase in loco-
motor activity. These data indicate an increased exploratory behaviour in the PROBIO animals56. The different 
behaviour between CTRL and PROBIO group suggests a higher exploration capability and attention/alert in the 
PROBIO group.
Notably, the detected pronounced changes in behaviour were accompanied by strongly increased expression 
levels of bdnf and several genes involved in serotonin signalling metabolism in the brain, while their expression 
in the gut was reduced. In fact, BDNF and the serotonergic system in the brain work synergistically and influence 
each other mutually on the transcriptional level, via epigenetic mechanisms, and by direct protective and regen-
erative effects of BDNF on serotonergic neurons throughout development and in later life57.
Most well established, the serotonergic system is linked to many behavioural traits58. As such, selective sero-
tonin reuptake-inhibitors (SSRIs) are the first-line treatment in severe depression and also recommended to treat 
generalized anxiety disorder59. Increased serotonin production and receptor expression in the zebrafish brain is 
therefore perfectly in line with the observed behavioural change induced by L. rhamnosus administration. In fact, 
both, the serotonergic system as well as BDNF levels, are well established effectors of the microbiota in the host. 
As such, Neufeld et al.60 found decreased expression of the serotonin receptor 1a (Htr1a) in germ-free mice60. In 
addition, a recent study showed increased levels of serotonin in the hippocampus of germ-free mice16, likely due 
to increased tryptophan uptake in the absence of tryptophan-metabolising microorganisms in the gut16. This 
study also revealed altered BDNF levels, which has now commonly been found in animal models with altered 
microbiota7,8,14,16. Moreover, the microbiota is directly involved in stimulating serotonin release from enterochro-
maffin cells in the gut epithelium, regulating enteric nervous system and vagus nerve activity33. Thus, our findings 
support existing literature connecting the microbiota with these systems also in the zebrafish.
Of note, we found different expression of bdnf and serotonin-related genes in the gut and the brain.
Recent findings show that BDNF plays an important role in gastrointestinal function and an increased level 
of BDNF in the colon of diarrhea-predominant irritable bowel syndrome (IBS) patients with abdominal pain was 
described61. However, the regulation of the expression of bdnf in gut is still unclear. Additionally, serotonin release 
in the gut and the enteric nervous system is regulated independently of regulation in the CNS62. It is therefore 
likely that L. rhamnosus supplementation has independent effects on these two systems, which does not preclude 
the possibility that both systems directly or indirectly contribute to the observed change in shoaling behaviour.
Analysis of the microbiota composition revealed that Proteobacteria, Fusobacteria and Firmicutes appeared 
consistently in the gut microbiota of zebrafish. Proteobacteria and Fusobacteria are common members of the gut 
microbiota in adult zebrafish and are especially well adapted to conditions of the fish gastro-intestinal tract in a 
surrounding aquatic environment63. The Firmicutes phylum (including Streptococcus spp. and Lactobacillus spp.) 
increased significantly in PROBIO group (t-test p value 0.038, Table S2) at the expense of representatives of the 
Proteobacteria fraction (including Vibrio spp. and Plesiomonas spp.) (Fig. 2D). This result is in agreement with 
previous studies reporting increased abundance of Lactobacillus and Streptococcus in zebrafish after probiotic 
administration, resulting in several beneficial effects44,46,47. Interestingly, a higher proportion of Proteobacteria, 
together with a lower abundance of Firmicutes, characterizes the intestinal microbiota dysbiosis in zebrafish 
model with inflammatory bowel disease (IBD)-like colitis and correlates significantly with enterocolitis severity, 
which mirrors changes in the human gut microbiota in IBD64.
Conclusion
So far most findings linking the microbiota with virtually all of the host physiological processes have originated 
from rodent studies. Compelling and rapidly accumulating evidence highlights the strong impact of the presence 
and activity of certain microbes in the gut on host physiology and behaviour. Notably, many studies have made 
use of animals raised in a sterile, germ-free environment. Using this approach it was found that the microbiota 
is critical for the host’s serotonergic system and tuning the stress response at a behavioural and endocrine level, 
which has further implications for our perception of stress-related psychiatric and gastrointestinal diseases. While 
these findings are stimulating, it has to be acknowledged that germ-free animals represent a highly artificial model 
that is uniquely useful to determine physiological processes influenced by the microbiota in a black-or-white 
manner, rather than a translatable model for human disease. Taken together, our data reveal specific, so far unde-
scribed behavioural and neurochemical changes in healthy zebrafish, induced by alteration of the enteric micro-
biota using a potential psychobiotic bacterium (L. rhamnosus IMC 501), demonstrating psychotropic effects on 
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the behavioural and molecular level. We may assert that the bidirectional signalling between microbiota and brain 
exists also in zebrafish, consolidating it as a valuable animal model for translational medicine.
While our data highlight the fact that supplementation with a probiotic is sufficient to induce sizeable effects 
on at least three levels of readout, the microbiota, neurochemistry and behaviour, further experimentation is 
necessary to connect these domains in a causal manner. Another limitation of this study, as in most other stud-
ies investigating gut-brain communication, is incomplete mechanistic insight into the routes connecting the 
increased abundance of the probiotic with altered neurochemistry and behaviour. In addition to modulation of 
the immune system via secreted metabolites and microbial cell wall material, especially differential stimulation 
of the vagus nerve have been shown to be among the routes of communication that mediates, for example, the 
antidepressant-like effects of L. rhamnosus in mammals11.
A deeper understanding of these communication mechanisms will be crucially important for the development 
of any microbiota-based therapeutic strategy for psychiatric diseases in human and animal health and for the 
discovery of alternative pathways and substrates to treat brain disorders that do not respond to available drugs.
Methods
Ethics Statement. All fish were treated in accordance with the Directive of the European Parliament and of 
the Council on the Protection of Animals Used for Scientific Purposes (directive 2010/63/EU) and in agreement 
with the Bioethical Committee of University of Napoli Federico II. All experiments involving fish were approved 
by the Bioethical Committee of the University of Naples Federico II (authorization protocol number 47339-2013). 
Following behavioural testing, the animals were euthanized by immersion in overdose 500 mg/ L-1 of 3-amin-
obenzoic acid ethyl ester (MS-222) buffered to pH 7.4 (Sigma–Aldrich, USA).
Animals and husbandry. Adult 4–6-month-old male and female zebrafish of heterozygous “wild type” 
strain were obtained from local commercial distributors (Carmar, Napoli, Italy). All fish were given at least 14 
days to acclimate to the laboratory environment and housed in groups of 12 fishes per 30-L tank. All tanks were 
filled with deionized water before introducing fish. Fish were fed two times daily with sterilized commercial 
food (Sera Vipagran, Germany). The room and water temperatures were maintained at 25–27 °C. Illumination 
(1010 ± 88 lx) was provided by ceiling-mounted fluorescent light tubes on a 14-h cycle (D:N = 14h:10h) consist-
ent with the standards of zebrafish care65. All fish used in this study were experimentally naïve. Two experimental 
groups were evaluated: a control group (CTRL, n = 12) and a probiotic-treated group (PROBIO, n = 12). The 
experiment was repeated twice to obtain biological duplicates.
Probiotic administration. The control group (CTRL) was fed twice per day with the commercial diet only 
and the probiotic-treated group (PROBIO) was fed twice per day with the commercial diet and twice per day 
with the lyophilized probiotic strain L. rhamnosus IMC 501, provided by Synbiotec (Camerino, Italy) via rearing 
water at a final concentration of 106 colony-forming units/g (0,01 g/l), according to the manufactory suggestions, 
for 28 days. Before the administration of the lyophilized L. rhamnosus IMC 501, a viability test was performed 
(see Supplementary information, Supplementary methods).
Behavioral testing. Fish swimming behaviour was video-recorded on the first day of probiotic treatment 
(T0) and at the end of treatment at 28 days (T4). Recording was performed always at the same hour (between 
14:00 and 15:00) with a Nikon D7000 camera for 6 min, acquired and analysed with 2D video tracking analysis 
and modelling tool (Tracker, California, USA) (www.cabrillo.edu/~dbrown/tracker/). In line with Blaser and 
Gerlai66 and Gerlai40, the video tracking data were used to determine the following behavioural measures: Average 
Distance (AD), Distance Variance (DV), Nearest Distance (ND), Occupied Area (or Shoal size area) (OA), Water 
Column Position (CP) and Shuttling Frequency (SF) (Supplementary Figure 1). In particular, AD represents 
the inter-individual distance and defines and calculates the average of all distances between a fish and its shoal 
members. Each fish thus will get an AD value and this value is calculated for all fish within a shoal and for any 
given moment of time sampled. As it takes the position of all fish in the shoal, AD is a powerful measure of shoal 
cohesion40. DV is the AD variance for each fish. Notably, this variability depends on the relative position of each 
fish within a shoal, so that its mean value, when calculated for the entire shoal, represents the homogeneity of the 
distribution of fish within that shoal. The less uniformly the shoal members are distributed, the larger the variance 
will be. ND calculates the nearest distance of each single fish to its closest neighbour, and represents a measure of 
the shoal cohesion less powerful than AD, but independent from the shoal size40. OA, which also measure shoal 
cohesion, calculates the occupied area of all animals in a temporal unit on a two-dimensional plane. CP represents 
the water column position (surface = 0) and indicates the deep preference of shoaling animals in the tank56. SF, 
which measures the locomotor activity of animals in the shoal66, is the total number of times that the fish entered 
the left, the right, the upper, and the lower halves of the tank. For AD, DV and ND measurements each fish was 
tracked on six frames randomly selected from each video. For SF measurements, five 10 sec intervals randomly 
selected from each video were analysed. For OA and CP analysis, ImageJ 1.49 software (National Institute of 
Mental Health, Bethesda, Maryland, USA) was used to select the areas occupied and the deep position of each 
fish in the water column in all video collected. Here, ten images were randomly selected from each video, one 
every twenty seconds.
Behaviour was evaluated by two independent, trained observers (intra-rater reliability > 0.90). Results are 
reported as means ± SEM. Two-way ANOVA with Sidak’s post-hoc test was used to evaluate the significance of 
the effect of the probiotic treatment, using GraphPad Prism version 6.00 for Windows (GraphPad Software, La 
Jolla California USA, www.graphpad.com).
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Gut microbiota analysis. Fish were dissected, brain and gut were entirely excised and stored in RNAlater 
(Ambion, Carlsbad CA, USA) at − 80 °C. The detailed description of the aseptic dissection procedure is reported 
in the Supplementary information (Supplementary methods).
After 30 min lysozyme treatment (50 mg/ml) at 37 °C, DNA was extracted from zebrafish gut (60 mg) using the 
QIAamp Stool Mini Kit (Qiagen, West Sussex, UK) with minor modifications44 and quantified using a Nanodrop 
TM-1000 Spectrophotometer (Thermo Scientific Ltd, DE, USA).
PCR was conducted to amplify the V3 region of the 16S rRNA gene using the primer pair P3-P267 and the 
V1-V2 region using the primer pair 27F-338RI/338RII63 (Table S2). PCR reactions consisted of 25 μ l ReadyMix 
Taq PCR Reaction Mix with MgCl2 (Sigma-Aldrich), 50 pmol of each of primer, 70 ng of DNA in a final volume of 
50 μ l. Touchdown thermal cycling was conducted using a GeneAmp PCR System 9700 (Perkin-Elmer, CA, USA), 
applying the conditions previously described67.
PCR products (PROBIO n = 5, CTRL n = 5 for each experiment, resulting in a total of ten samples for each 
group, PROBIO and CTRL, respectively) were purified using the QIAquick PCR Purification Kit (Qiagen). 
Libraries for sequencing were prepared using the Ion Plus Fragment Library Kit (Life Technologies, USA) and 
quantified using the Ion Library Quantitation Kit (Life Technologies) and concentrations were adjusted to 26 
pM. The emulsion PCR was carried out using the Ion PGM Template OT2 400 Template Kit (Life Technologies) 
according to the manufacturer’s instructions. Multiplexed sequencing was carried out on a 318 chip using the Ion 
Torrent PGM system and employing the Ion Sequencing 400 kit (Life Technologies) according to the supplier’s 
instructions. After sequencing, the sequence reads were filtered and trimmed by the PGM software to remove low 
quality and polyclonal sequences and quality control was performed using Quantitative Insights Into Microbial 
Ecology v1.8.0 (QIIME) (quality score > 25). In order to calculate downstream diversity measures (alpha and 
beta diversity indices, UniFrac analysis), 16S rRNA Operational Taxonomic Units (OTUs) were defined at > 97% 
sequence identity. All reads were classified to the lowest possible taxonomic rank using QIIME and a reference 
dataset from the Ribosomal Database Project. OTUs were assigned using Uclust. The hierarchical clustering based 
on population profiles of most common and abundant taxa was performed using UPGMA clustering on the 
distance matrix of OTU abundance. Ecological metrics were calculated on rarefied OTU tables with QIIME to 
assess sampling depth coverage using observed species, Chao1, Shannon’s diversity index and Good’s coverage. 
QIIME was also used to calculate Beta diversity metrics among samples using weighted Unifrac distances22 and 
Bray-Curtis similarity44. The distance matrix was represented by a dimensional principal coordinates analysis 
(PCoA) plots. Taxonomy of intestinal bacterial communities data are presented as means ± standard error of the 
mean (SEM). Statistical analysis was performed using the two-tailed t test.
RNA extraction and expression analysis. Total RNA was separately extracted from brain and gut sam-
ples using the Pure Link RNA Mini Kit (Ambion, Carlsbad CA, USA) and DNase treatment was performed 
using the Pure Link DNase Set (Ambion). RNA was quantified using a Nanodrop ND-2000 Spectrophotometer 
(Thermo Scientific). Total RNA was reverse transcribed using the SuperScript VILO cDNA Synthesis Kit 
(Ambion) and an oligo dT primer. Expression levels of the Danio rerio genes bdnf, tph1a, tph1b, tph2, htr1aa, 
slc6a4a and mao in gut and brain were evaluated by Real Time PCR. PCR amplifications were conducted on 30 ng 
of first-strand cDNA using the primer pairs listed in Table S3 and the Power SYBR Green Master mix (Ambion). 
The reactions were conducted in technical triplicates and biological duplicates and were run in the 7500 ABI 
Thermal Cycler (Applied Biosystems) using the thermal cycle: 50 °C, 2 min; 95 °C, 10 min; 40 cycles of 95 °C, 
15 sec and 60 °C, 1 min, followed by a melting curve cycle.
The Real-Time PCR Miner online tool68 was used to calculate the PCR efficiency (E) and optimal threshold cycle 
(CT) for each well. The mean relative expression ratio and standard error of the target genes was calculated using the 
β -actin gene as the endogenous control applying the formula (1 + E target)–CT target/(1 + E control)−CT control.
Statistical significance of differences in expression levels of the target genes between CTRL and PROBIO 
groups was assessed by two-tailed t-tests.
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